Search

Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

ASCRS: 2025

Drug Delivery and the Quest for Control

Douglas Rhee, MD

Show Description +

Douglas Rhee, MD, spoke during Glaucoma Subspecialty Day at the ASCRS annual meeting about drug delivery and sustained-release devices. He examines the evidence behind existing and commercially available implants and reviews their comparable levels of IOP reduction and safety.

Posted: 5/01/2025

Keywords:

ASCRS

•

glaucoma

•

drug delivery

•

IOP reduction

Up Next

Government Relations and Getting Involved

Government Relations and Getting Involved

Sue Hewitt, MD

Tips and Tricks for Direct SLT

Tips and Tricks for Direct SLT

Christine Funke, MD

$Assessing Refractive Astigmatism Outcomes With Toric IOL Alignment$

Assessing Refractive Astigmatism Outcomes With Toric IOL Alignment

Ben LaHood, MBChB, PGDipOphth, PhD, FRANZCO

Micro-Shockwave Therapy of the Sclera and Lens for Accommodation Restoration

Micro-Shockwave Therapy of the Sclera and Lens for Accommodation Restoration

Ronald R. Krueger, MD, MSE

Multidosing Mapped: Where States Stand on Medication Multidosing

Multidosing Mapped: Where States Stand on Medication Multidosing

Margaret A. Tharp, BSc

Digital Visualization in Ophthalmic Surgery

Digital Visualization in Ophthalmic Surgery

Robert Weinstock, MD

Real-World Evidence and Visual Outcomes of a Full Visual Range IOL

Real-World Evidence and Visual Outcomes of a Full Visual Range IOL

Priya Mathews, MD

Accelerated Epi-On Crosslinking With Localized Riboflavin and Oxygenation

Accelerated Epi-On Crosslinking With Localized Riboflavin and Oxygenation

Ali Nowrouzi, MD, FEBO, FRCS

$Refractive Stability and Visual Acuity of a Modular Shape-Changing IOL$

Refractive Stability and Visual Acuity of a Modular Shape-Changing IOL

Steven Dell, MD

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Y. Ralph Chu, MD

Achieving Precise Toric IOL Alignment

Achieving Precise Toric IOL Alignment

Douglas Koch, MD

Big Data and AI in Glaucoma

Big Data and AI in Glaucoma

Robert Chang, MD

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Rachel Schneider, MD

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Lisa Feulner, MD, PhD

Cataract Surgery at Physiologic Intraocular Pressure

Cataract Surgery at Physiologic Intraocular Pressure

Matthew Rauen, MD

Imaging Update

Sanjay Asrani, MD

Intravitreal Drugs and the Glaucomas That Ensue

Intravitreal Drugs and the Glaucomas That Ensue

Lilian Nguyen, MD

Back to All Videos

Drug Delivery and the Quest for Control

Douglas Rhee, MD

Douglas Rhee, MD, spoke during Glaucoma Subspecialty Day at the ASCRS annual meeting about drug delivery and sustained-release devices. He examines the evidence behind existing and commercially available implants and reviews their comparable levels of IOP reduction and safety.

Posted: 5/01/2025

Keywords:

ASCRS

•

glaucoma

•

drug delivery

•

IOP reduction

Please log in to leave a comment.

More From ASCRS: 2025 Coverage

Achieving Precise Toric IOL Alignment

Achieving Precise Toric IOL Alignment

Douglas Koch, MD

Big Data and AI in Glaucoma

Big Data and AI in Glaucoma

Robert Chang, MD

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Rachel Schneider, MD

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Lisa Feulner, MD, PhD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2025.